Photo of Giselle Sholler from LinkedIn
May 4, 2024, 14:22
Giselle Sholler: Our preclinical work obtaining DFMO approval is available
Giselle Sholler,
“Our newest publication highlights the preclinical work that was critical in obtaining DFMO approval is available!
The approval required a single arm trial with ‘substantial confirmatory evidence’ shown here.
So proud of our team, especially Divya for her ‘first author’ paper – congratulations!”
Additional information.
Source: Giselle Sholler/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14